• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.

作者信息

Gebauer G, Müller-Ruchholtz W

机构信息

Department of Gynecology and Obstetrics, University Erlangen-Nuremberg, Germany.

出版信息

Anticancer Res. 1997 Jul-Aug;17(4A):2731-4.

PMID:9252706
Abstract

Tumor markers CEA, CA19-9, CA15-3, CA125, AFP, beta-HCG, SCC were measured quantitatively in serum, tumor tissue and healthy colonic mucosa of patients with colorectal cancer. We wanted to investigate whether there is a difference in concentration between patients with and without recurrence of cancer. During the follow-up period 14 of 38 patients showed tumor recurrence. Patients with cancer relapse had higher preoperative serum levels of CEA and CA19-9 and significantly higher concentrations in their histologically normal colonic mucosa of CEA, CA19-9, SCC and lower ones of CA15-3. The highest values of CEA, CA19-9, and SCC occurred in the mucosa of patients developing local cancer recurrence. Marker concentrations in tumor tissues themselves did not differ between patients with or without tumor relapse. Though this should be confirmed in a larger number of cases we conclude from these results that tumor marker concentrations in healthy colonic mucosa of patients with colorectal cancer may become valuable indicators of the risk of tumor recurrence.

摘要

相似文献

1
Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.
Anticancer Res. 1997 Jul-Aug;17(4A):2731-4.
2
Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.结直肠癌患者正常组织和恶性组织中的肿瘤标志物浓度及其预后相关性。
Anticancer Res. 1997 Jul-Aug;17(4B):2939-42.
3
Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer.癌胚抗原和CA19-9:组织中定量标志物测量对结直肠癌预后的影响
Cancer Detect Prev. 2001;25(4):344-51.
4
The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.癌胚抗原、糖类抗原19-9和糖类抗原72-4在结直肠癌复发检测中的意义
Anticancer Res. 2000 Nov-Dec;20(6D):5237-44.
5
Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.结直肠癌中癌胚抗原(CEA)和糖类抗原19-9(CA 19-9)血清水平预后价值的多变量分析
Anticancer Res. 2000 Nov-Dec;20(6D):5195-8.
6
[The value of tumor markers in colorectal cancer].[肿瘤标志物在结直肠癌中的价值]
Leber Magen Darm. 1989 Jan;19(1):18-25.
7
Slope analysis of CA19-9 and CEA for predicting recurrence in colorectal cancer patients.CA19-9和CEA用于预测结直肠癌患者复发的斜率分析。
Anticancer Res. 1997 Mar-Apr;17(2B):1379-82.
8
Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.子宫颈腺癌患者的肿瘤标志物CA 125、鳞状细胞癌抗原和癌胚抗原。
Obstet Gynecol. 1989 Apr;73(4):661-8.
9
[Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].[抗原(癌胚抗原和糖类抗原19-9)在结直肠癌诊断及预后中的应用]
Pol Merkur Lekarski. 2002 Jan;12(67):77-80.
10
Tumor markers in staging and prognosis of colorectal carcinoma.肿瘤标志物在结直肠癌分期及预后中的作用
Neoplasma. 2008;55(2):138-42.

引用本文的文献

1
Regulation of the metastatic cell phenotype by sialylated glycans.唾液酸化糖缀合物对转移性细胞表型的调控。
Cancer Metastasis Rev. 2012 Dec;31(3-4):501-18. doi: 10.1007/s10555-012-9359-7.